Extensively drug-resistant TB kills 49% of patients, study finds

11/7/2008 | ABC News

Researchers found that the survival rates of patients with extensively drug-resistant tuberculosis are lower compared with those of patients with multidrug-resistant TB. The finding highlights the importance of administering more aggressive treatment therapies in patients with XDR-TB, the researchers said.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA